• EN - English
  • IT - italiano
Parliamentary question - P-003960/2021Parliamentary question

Withdrawal of vaccine authorisation

Priority question for written answer  P-003960/2021
to the Commission
Rule 138
Francesca Donato (ID)

The EU has granted conditional approval for the emergency use of COVID-19 vaccines, with a six-week review of post-vaccination safety data[1].

To date, EUDRAVIGILANCE has received around 20 000 reports of deaths probably related to the vaccines and some 700 000 adverse reactions, 9% of which severe. These data are, however, underestimated when it comes to the true magnitude of adverse effects, given that there is no active surveillance. The EMA has recently updated the list of adverse reactions to vaccines, adding new diseases[2].

Moreover, the trend in infections among vaccinated people in countries such as Israel and the UK shows that the vaccines themselves are not effective against the variants that are currently predominant.

The possible long-term reactions to mRNA vaccines, which have never before been authorised for humans, remain unknown[3].

In view of this, will the Commission:

Last updated: 27 August 2021
Legal notice - Privacy policy